In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion with tremendous potential to grow. This total comprises eight different market segments. To find out more, please request a Sample.
The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems.
Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution.
This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.
Main Segments Included:
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "ground up" approach, which includes primary and secondary research methods.